Banned bread: why does the US allow additives that

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone ChannelTrader #59584
335

Banned bread: why does the US allow
additives that Europe says are unsafe?
China, Brazil and members of the EU have weighed
the potential risks and outlawed chemicals found in US loaves
< >



Give us this day our daily foam expander. It may sound odd, but in America, your loaf of bread can contain ingredients with industrial applications – additives that also appear in things like yoga mats, pesticides, hair straighteners, explosives and petroleum products.

Some of these chemicals, used as optional whiteners, dough conditioners and rising agents, may be harmful to human health. Potassium bromate, a potent oxidizer that helps bread rise, has been linked to kidney and thyroid cancers in rodents. Azodicarbonamide (ACA), a chemical that forms bubbles in foams and plastics like vinyl, is used to bleach and leaven dough – but when baked, it, too, has been linked to cancer in lab animals.

Other countries, including China, Brazil and members of the European Union, have weighed the potential risks and decided to outlaw potassium bromate in food. India banned it in 2016, and the UK has forbidden it since 1990. Azodicarbonamide has been banned for consumption by the European Union for over a decade.

But despite petitions from several advocacy groups – some dating back decades – the US Food and Drug Administration (FDA) still considers these to be Gras or “generally recognized as safe” to eat, though plenty of experts disagree.

“The system for ensuring that ingredients added to food are safe is broken,” said Lisa Lefferts, senior scientist at the consumer advocacy group Center for Science in the Public Interest. Lefferts, who specializes in food additives, said that once a substance was in the food supply, the FDA rarely took further action, even when there was evidence that it isn’t safe.

The Center for Science in the Public Interest petitioned the FDA to ban potassium bromate two decades ago due to cancer concerns, but the FDA’s response, according to a letter from the agency, was that it couldn’t examine the issue due to “limited availability of resources and other agency priorities”.

That has spurred consumers to take matters in their own hands. Bowing to pressure from a petition started by Vani Hari, author of the popular blog FoodBabe.com, numerous chains including Subway, Wendy’s, McDonald’s and White Castle dumped azodicarbonamide in 2014. That same year, the not-for-profit Environmental Working Group (EWG) released a list of more than 500 products containing ACA. Today, that number is about 200.
Bisphenol: what to know about the chemicals in water bottles and cans

EWG has also found potassium bromate, sometimes appearing on food labels as bromated flour, in at least 100 items sold in the US, including Swanson’s chicken pot pie, Goya’s chorizo croquettes and Nathan’s pepperoni and provolone stromboli.

Reached for comment, Conagra Brands, which recently acquired Swanson foods, said the company intended to phase out potassium bromate in their chicken pot pies.

As more American consumers become savvy to these ingredients, more companies are phasing them out – but not everyone. Arby’s still has ACA in its croissants, French bread sticks, and sourdough breakfast bread while Pillsbury includes it in tubes of breadstick dough. The Guardian contacted these companies for comment and will update this article upon receiving a response. Pillsbury did reply, saying it complied with all FDA regulations.

Those regulations allow only very small amounts of ACA and PB in bread – just 45 and 75 parts per million respectively. The FDA says those amounts make the risk of exposure to toxic byproducts negligible.

“If [an additive] really is a carcinogen in humans, then no amount would be considered ‘safe’,” said Ryan Marino, an emergency medical toxicologist at the University of Pittsburgh.

According to Marino, part of the reason data is scarce on this topic is that the industry itself can determine if chemical additives are safe. The FDA does not review every additive that makes its way into food. Instead, companies can rely on their own experts to determine what’s safe and what isn’t. And once something was determined as Gras, Marino said, “there is not often any financial incentive for additional testing”.

ACA is a good example. First discovered around 1959, the chemical entered the bread supply only three years later. By 1980, the bright yellow crystals were linked to asthma in workers exposed to the chemical while manufacturing plastics. But the concern for bread-eaters comes from what happens to ACA when it’s heated or baked, breaking down into two chemicals: semicarbazide and urethane. Urethane is “reasonably anticipated” to be a human carcinogen, according to the US Department of Health and Human Services, while semicarbazide has shown toxicity in some animals, but not yet humans.

The FDA told the Guardian that consumers had no reason to be concerned. “All food additives are carefully regulated by federal authorities and various international organizations to ensure that foods are safe to eat and are accurately labeled,” a spokesperson said via email. “As part of FDA’s overall commitment to ensure the safety of the food supply, the agency uses an extensive, science-based process to evaluate the safety of food additives. Further, FDA continues to monitor the science on food ingredients and is prepared to take appropriate action if there are safety concerns.”

It’s not just so-called dough conditioners in bread. Two preservatives, BHA and BHT, subject to strong restrictions in the EU, are widely used in baked goods in the US. These emulsifiers keep fats and oils from spoiling, but the International Agency for Research on Cancer suggests there is sufficient evidence that BHA causes tumor growth in lab animals, with more limited evidence for the same in BHT.
‘It’s killing us’: why firefighters are battling to ban flame retardants

The data on humans is lacking, but the FDA has allowed these ingredients in small amounts since before the 1950s. “The FDA has studied the use of BHA and BHT in foods for decades and has determined that at the very low levels at which they are used, they do not pose safety concerns,” the agency spokesperson said.

While some companies are removing controversial ingredients, their replacements aren’t necessarily much better or all that different. “A number of other companies have switched from potassium bromate to potassium iodate in their bread, but potassium iodate is not well tested and may also pose a slight cancer risk,” Lefferts said. “It might also lead to excessive iodine intake. While iodine is an essential trace element that the body needs, too much can be harmful.”

The World Health Organization has recommended against adding potassium iodate to flour since 1965, yet the EWG lists more than 600 products that include potassium iodate, including Sara Lee hot dog buns, Safeway’s Signature Select whole wheat bread and Oroweat Italian bread.

But some replacements carry fewer risks. Many of the companies that removed ACA, including Subway, replaced it with ascorbic acid, also known as vitamin C. For many companies, these additives simply come down to cost: they’re cheaper than the alternatives.

What can bread consumers do other than diligently check the ingredients? Olga Naidenko, senior science adviser at EWG, suggested supporting independent bakeries that nix these additives or even baking at home. But that assumes time and money, which Naidenko doesn’t think should be necessary.

“In EWG’s view, it is important for companies to start removing chemicals associated with health risks, so that shoppers don’t have to have a chemistry degree in order to decipher food labels,” said Naidenko. “Due to the Gras loophole and insufficient FDA oversight, there really has been a lag on generation of toxicity and safety data for chemicals used in foods.”

For the past two years, the Environmental Defense Fund has been challenging the Gras rule in federal court, seeking to have the regulatory process declared “unlawful”. As of April 2019, the request is awaiting a judge’s ruling. In the meantime, consumers concerned about additives in bread may have to resort to Hari’s strategy: petition the companies themselves.

Americans are routinely exposed to dangerous chemicals that have long been banned in countries such as the UK, Germany and France. Of the 40,000 chemicals used in consumer products in the US, according to the EPA, only one percent have been tested for human safety.

With support from our readers, The Guardian aims to raise $150,000 for a six-month project on how these levels of toxicity are impacting our lives. We will explore the worrying health implications of living in an environment that can expose us to chemical contamination on a daily basis.

Your support will enable us to examine the power of the $640bn chemical industry – which has a lobby that’s currently better funded than the NRA – and raise public awareness about its influence. This series will help us all to make sense of the complex science and conflicting messages about what’s safe, what’s harmful and what remains unknown.

Reader support protects The Guardian’s independence and ensures our journalism remains open to all. Our editorial independence allows us to fight for transparency and accountability – and deliver the facts with clarity.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on CDW's Market Position and P/E Ratio Analysis

Updated Category News Views 123

Analyzing CDW's Current Market Performance CDW Inc.'s current stock price stands at $164.29, reflecting a notable increase of 2.59% during the ongoing market session. Despite this uptick, shareholders might be concerned as the stock has experienced a decline of 6.53% over the past month and a more significant drop of 24.18% over the last year. With these figures, it...

Continue Reading
What the Recent Earnings Report Means for FactSet Research

Updated Category News Views 135

FactSet Research Exceeds Expectations in Q1 Performance FactSet Research Systems Inc. (NYSE: FDS) has reported first-quarter results that exceeded analyst expectations, showcasing strong performance in a competitive financial market. The company achieved first-quarter sales totaling $607.6 million, surpassing the anticipated $600.5 million, which reflects a commendable...

Continue Reading
Dime Community Bancshares Unveils Executive Transition Plans

Updated Category News Views 180

Dime Community Bancshares Executive Changes Dime Community Bancshares, Inc. (NASDAQ: DCOM) recently announced significant changes in its leadership team as part of a strategic succession plan. This initiative reflects the company’s commitment to fostering a robust executive structure and enhancing its operational growth. Leadership Transition Details As Dime prepares...

Continue Reading
Hygiene Products Industry on Track to Reach $14.62 Billion

Updated Category News Views 112

Overview of the Antiseptic Products Market The global antiseptic products market is projected to experience remarkable growth, reaching an estimated value of USD 10.85 billion in 2025, and anticipated to climb to USD 14.62 billion by 2032. This represents a compound annual growth rate (CAGR) of 4.35% during the period. As health-conscious consumers become increasingly...

Continue Reading
China's Enduring Commitment to Global Peace and Prosperity

Updated Category News Views 91

China's Historical Role in the UN The United Nations (UN) stands as a testament to humanity's resolve for peace, shaped significantly by historical events like the World Anti-Fascist War. This war saw the Allies, including China, rally against the Axis powers, fostering a crucial international alliance. Founded as a result of collective victories, the UN embodies the...

Continue Reading